Assessing resectability of colorectal liver metastases: How do different subspecialties interpret the same data?

BACKGROUND Multimodal treatment of colorectal liver metastases (CRLMs) relies on precise upfront assessment of resectability. Variability in the definition of resectable disease and the importance of early consultation by a liver surgeon have been reported. In this pilot study we investigated the initial resectability assessment and patterns of referral of patients with CRLMs. METHODS Surgeons and medical oncologists involved in the management of colorectal cancer at 2 academic institutions and affiliated community hospitals were surveyed. Opinions were sought regarding resectability of CRLMs and the type of initial specialty referral (hepatobiliary surgery, medical oncology, palliative care or other) in 6 clinical cases derived from actual cases of successfully performed 1- or 2-stage resection/ablation of hepatic disease. Case scenarios were selected to illustrate critical aspects of assessment of resectability, best therapeutic approaches and specialty referral. Standard statistical analyses were performed. RESULTS Of the 75 surgeons contacted, 64 responded (response rate 85%; 372 resectability assessments completed). Hepatic metastases were more often considered resectable by hepatobiliary surgeons than all other respondents (92% v. 57%, p < 0.001). Upfront systemic therapy was most commonly prioritized by surgical oncologists (p = 0.01). Hepatobiliary referral was still considered in 73% of "unresectable" assessments by colorectal surgeons, 59% of those by general surgeons, 57% of those by medical oncologists and 33% of those by surgical oncologists (p = 0.1). CONCLUSION Assessment of resectability varied significantly between specialties, and resectability was often underestimated by nonhepatobiliary surgeons. Hepatobiliary referral was not considered in a substantial proportion of cases erroneously deemed unresectable. These disparities result largely from an imprecise understanding of modern surgical indications for resection of CRLMs.

[1]  T. Treasure,et al.  Surgical management and outcomes of colorectal cancer liver metastases. , 2017, Cancer epidemiology.

[2]  W. Chapman,et al.  Time-to-Surgery and Survival Outcomes in Resectable Colorectal Liver Metastases: A Multi-Institutional Evaluation. , 2016, Journal of the American College of Surgeons.

[3]  M. D'Angelica,et al.  Metastatic Colorectal Cancer to the Liver: Involve the Surgeon Early and Often , 2015, Annals of Surgical Oncology.

[4]  S. Hendren,et al.  Surgical Referral for Colorectal Liver Metastases: A Population-Based Survey , 2015, Annals of Surgical Oncology.

[5]  F. Lordick,et al.  Discrepancies between medical oncologists and surgeons in assessment of resectability and indication for chemotherapy in patients with colorectal liver metastases , 2014, The British journal of surgery.

[6]  M. Choti,et al.  Influence of Nonclinical Factors on Choice of Therapy for Early Hepatocellular Carcinoma , 2013, Annals of Surgical Oncology.

[7]  J. Vauthey,et al.  Effect of specialist decision‐making on treatment strategies for colorectal liver metastases , 2012, The British journal of surgery.

[8]  M. Choti,et al.  Treating Patients with Colon Cancer Liver Metastasis: A Nationwide Analysis of Therapeutic Decision Making , 2012, Annals of Surgical Oncology.

[9]  R. Auer,et al.  Evaluating agreement regarding the resectability of colorectal liver metastases: a national case-based survey of hepatic surgeons. , 2012, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[10]  M. Hollands,et al.  A Systematic Review of Clinical Response and Survival Outcomes of Downsizing Systemic Chemotherapy and Rescue Liver Surgery in Patients with Initially Unresectable Colorectal Liver Metastases , 2012, Annals of surgical oncology.

[11]  M. Choti,et al.  Understanding surgical decision making in early hepatocellular carcinoma. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  M. Choti,et al.  Selection of Patients for Resection of Hepatic Colorectal Metastases: Expert Consensus Statement , 2006, Annals of Surgical Oncology.

[13]  P. Bossuyt,et al.  Imaging and treatment of patients with colorectal liver metastases in the Netherlands: a survey. , 2006, The Netherlands journal of medicine.

[14]  L H Blumgart,et al.  Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. , 1999, Annals of surgery.

[15]  D. Timmermans,et al.  Analysis of the variety in surgeons' decision strategies for the management of left colonic emergencies. , 1997, Medical care.